FY24 consensus $8.56. Raises FY24 revenue view to $63.1B-$64.3B from $62.7B-$64.2B, consensus $63.83B.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- MRK Upcoming Earnings Report: What to Expect?
- Options Volatility and Implied Earnings Moves This Week, April 22 – April 26, 2024
- Moderna Stock (NASDAQ:MRNA): This mRNA Tech Pioneer Has Rebound Potential
- Merck price target raised to $143 from $140 at Berenberg
- Piper Sandler pharmaceuticals analysts hold an analyst/industry conference call
